Bayer ‘All Hands On Deck’ For US Consumer Business Turnaround
Executive Summary
“There is a ton of work still for us to do,” Erica Mann, Bayer’s global consumer head, said after the firm reported disappointing second-quarter results. The root of the problem is over-estimating the revenue boost from former Merck & Co. brands, the firm says.
You may also be interested in...
Bayer Trims Consumer Portfolio Selling Solarcaine, Other US, Canada Skin Care Brands To WellSpring
WellSpring, owned by private equity firm Avista Capital Partners, purchasing Solarcaine, diaper rash and skin protectant A+D and Canadian brands Cortate and Complex 15. Bayer’s long-term commitment to consumer health one of key issues facing its next CEO, Bill Anderson.
Bayer Consumer Chief Identifies 'Root Causes' Of Slump, Initiates Growth 'Fix'
Bayer's Consumer Health chief Heiko Schipper hopes a focus on innovation and a leaner portfolio will help return business to mid-single-digit growth by 2022. German firm has identified North American business as the "key area to fix."
Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth
Bayer's Consumer Health chief Heiko Schipper is hoping a focus on innovation and a leaner portfolio will help return the business to mid-single-digit growth by 2022. The German firm has identified its North American business as the 'key area to fix'.